Cantor Fitzgerald Upgrades Atlassian (NASDAQ:TEAM) to “Overweight”
otakuyassine3@gmail.com Cantor Fitzgerald upgraded shares of Atlassian (NASDAQ:TEAM – Free Report) from a neutral rating to...
Cantor
Cantor Fitzgerald Issues Positive Forecast for STOK Earnings
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities research analysts at Cantor Fitzgerald lifted...
Cantor Fitzgerald Initiates Coverage on Robinhood Markets (NASDAQ:HOOD)
Cantor Fitzgerald started coverage on shares of Robinhood Markets (NASDAQ:HOOD – Free Report) in a...
CrowdStrike’s (CRWD) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of CrowdStrike (NASDAQ:CRWD – Free Report) in...
Vertex Pharmaceuticals’ (VRTX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “overweight” rating restated by stock...
Amprius Technologies (NYSE:AMPX) Research Coverage Started at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of Amprius Technologies (NYSE:AMPX – Free Report) in a...
Cantor Fitzgerald Reaffirms Overweight Rating for Celldex Therapeutics (NASDAQ:CLDX)
Celldex Therapeutics (NASDAQ:CLDX – Get Free Report)‘s stock had its “overweight” rating restated by stock...
Micron Technology (NASDAQ:MU) Given New $130.00 Price Target at Cantor Fitzgerald
Micron Technology (NASDAQ:MU – Free Report) had its target price decreased by Cantor Fitzgerald from...